Ironwood Pharmaceuticals (IRWD) Competitors $3.63 +0.10 (+2.83%) (As of 10:33 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IRWD vs. CLDX, MNKD, DVAX, BCRX, NVAX, MYGN, INVA, OPK, SGMO, and EBSShould you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include Celldex Therapeutics (CLDX), MannKind (MNKD), Dynavax Technologies (DVAX), BioCryst Pharmaceuticals (BCRX), Novavax (NVAX), Myriad Genetics (MYGN), Innoviva (INVA), OPKO Health (OPK), Sangamo Therapeutics (SGMO), and Emergent BioSolutions (EBS). These companies are all part of the "biotechnology" industry. Ironwood Pharmaceuticals vs. Celldex Therapeutics MannKind Dynavax Technologies BioCryst Pharmaceuticals Novavax Myriad Genetics Innoviva OPKO Health Sangamo Therapeutics Emergent BioSolutions Ironwood Pharmaceuticals (NASDAQ:IRWD) and Celldex Therapeutics (NASDAQ:CLDX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Do analysts rate IRWD or CLDX? Ironwood Pharmaceuticals presently has a consensus price target of $10.40, suggesting a potential upside of 186.50%. Celldex Therapeutics has a consensus price target of $62.25, suggesting a potential upside of 141.84%. Given Ironwood Pharmaceuticals' higher probable upside, equities research analysts plainly believe Ironwood Pharmaceuticals is more favorable than Celldex Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ironwood Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Celldex Therapeutics 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89 Does the MarketBeat Community prefer IRWD or CLDX? Celldex Therapeutics received 107 more outperform votes than Ironwood Pharmaceuticals when rated by MarketBeat users. Likewise, 75.15% of users gave Celldex Therapeutics an outperform vote while only 61.08% of users gave Ironwood Pharmaceuticals an outperform vote. CompanyUnderperformOutperformIronwood PharmaceuticalsOutperform Votes51061.08% Underperform Votes32538.92% Celldex TherapeuticsOutperform Votes61775.15% Underperform Votes20424.85% Which has more risk & volatility, IRWD or CLDX? Ironwood Pharmaceuticals has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Celldex Therapeutics has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Is IRWD or CLDX more profitable? Ironwood Pharmaceuticals has a net margin of -0.65% compared to Celldex Therapeutics' net margin of -1,544.32%. Ironwood Pharmaceuticals' return on equity of -0.96% beat Celldex Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Ironwood Pharmaceuticals-0.65% -0.96% 0.74% Celldex Therapeutics -1,544.32%-19.75%-18.86% Which has preferable earnings and valuation, IRWD or CLDX? Celldex Therapeutics has lower revenue, but higher earnings than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than Celldex Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIronwood Pharmaceuticals$378.42M1.54-$1.00B-$0.03-121.00Celldex Therapeutics$9.98M171.18-$141.43M-$2.57-10.02 Does the media prefer IRWD or CLDX? In the previous week, Ironwood Pharmaceuticals had 6 more articles in the media than Celldex Therapeutics. MarketBeat recorded 8 mentions for Ironwood Pharmaceuticals and 2 mentions for Celldex Therapeutics. Celldex Therapeutics' average media sentiment score of 1.30 beat Ironwood Pharmaceuticals' score of 0.03 indicating that Celldex Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ironwood Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Celldex Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCelldex Therapeutics beats Ironwood Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Ad The Tomorrow InvestorThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.Click here to see how a new partnership could catapult this drone suppliers' growth Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRWD vs. The Competition Export to ExcelMetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$580.90M$6.84B$5.14B$9.30BDividend YieldN/A3.06%4.81%4.06%P/E Ratio-121.0010.77135.3017.49Price / Sales1.54284.121,186.56136.36Price / CashN/A56.6540.4237.95Price / Book-1.645.374.874.92Net Income-$1.00B$151.75M$118.61M$225.42M7 Day Performance-1.63%-4.72%15.32%-1.20%1 Month Performance-9.70%2.09%15.26%7.09%1 Year Performance-67.41%16.12%34.42%22.83% Ironwood Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRWDIronwood Pharmaceuticals4.1096 of 5 stars$3.63+2.8%$10.40+186.5%-68.3%$580.90M$378.42M-121.00220CLDXCelldex Therapeutics3.0716 of 5 stars$26.26+3.3%$62.25+137.1%-29.9%$1.74B$6.88M-9.89160MNKDMannKind3.5182 of 5 stars$6.26-4.3%$8.67+38.4%+50.5%$1.73B$267.20M89.29400News CoverageDVAXDynavax Technologies4.8018 of 5 stars$12.99+0.2%$22.00+69.4%-5.6%$1.71B$260.81M100.00408News CoverageBCRXBioCryst Pharmaceuticals3.8591 of 5 stars$7.36-2.3%$15.60+112.0%+21.0%$1.52B$412.58M-12.34530Positive NewsNVAXNovavax3.8056 of 5 stars$9.21+1.1%$17.83+93.6%+66.7%$1.48B$847.25M-4.031,543MYGNMyriad Genetics4.5684 of 5 stars$14.14-2.0%$24.27+71.7%-33.4%$1.29B$823.60M-11.102,700INVAInnoviva2.1507 of 5 stars$18.45-0.7%N/A+18.6%$1.15B$310.46M26.93112Short Interest ↓Positive NewsOPKOPKO Health4.4495 of 5 stars$1.55-2.8%$2.75+78.0%+4.2%$1.05B$711.41M-8.343,930Positive NewsSGMOSangamo Therapeutics1.8846 of 5 stars$2.53+23.2%$7.00+177.2%+579.4%$526.84M$176.23M-3.11480Analyst UpgradeGap DownHigh Trading VolumeEBSEmergent BioSolutions4.1689 of 5 stars$8.92+5.2%$14.00+57.0%+268.9%$483.32M$1.09B-2.071,600Insider TradeNews Coverage Related Companies and Tools Related Companies Celldex Therapeutics Alternatives MannKind Alternatives Dynavax Technologies Alternatives BioCryst Pharmaceuticals Alternatives Novavax Alternatives Myriad Genetics Alternatives Innoviva Alternatives OPKO Health Alternatives Sangamo Therapeutics Alternatives Emergent BioSolutions Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRWD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
